Heart failure in African Americans: disparities can be overcome.
نویسندگان
چکیده
African Americans are disproportionately affected by heart failure, with a high prevalence at an early age. Hypertension, diabetes, obesity, and chronic kidney disease are all common in African Americans and all predispose to heart failure. Neurohormonal imbalances, endothelial dysfunction, genetic polymorphisms, and socioeconomic factors also contribute. In general, the same evidence-based treatment guidelines that apply to white patients with heart failure also apply to African Americans. However, the combination of hydralazine and isosorbide dinitrate is advised specifically for African Americans.
منابع مشابه
Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.
BACKGROUND AND PURPOSE Population-wide reductions in cardiovascular disease incidence and mortality have not been shared equally by African Americans. The burden of cardiovascular disease in the African American community remains high and is a primary cause of disparities in life expectancy between African Americans and whites. The objectives of the present scientific statement are to describe ...
متن کاملDisparities in lipid management for African Americans and Caucasians with coronary artery disease: A national cross-sectional study
BACKGROUND Individuals with coronary artery disease are at high risk for adverse health outcomes. This risk can be diminished by aggressive lipid management, but adherence to lipid management guidelines is far from ideal and substantial racial disparities in care have been reported. Lipid treatment and goal attainment information is not readily available for large patient populations seen in th...
متن کاملInfluence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs.
Inferior outcomes after kidney transplantation among African Americans are poorly understood. It was hypothesized that unequal access to medical care among transplant recipients might contribute to worse posttransplantation outcomes among African Americans and that racial disparities in kidney transplant outcomes would be less pronounced among patients who receive health care within versus outs...
متن کاملWhat's Wrong with Race-Based Medicine?: Genes, Drugs, and Health Disparities
In June 2005, the Food and Drug Administration (FDA) announced a historic decision: it approved the first pharmaceutical indicated for a specific race.1 BiDil, a combination drug that relaxes the blood vessels, was authorized to treat heart failure in self-identified black patients. BiDil had been tested in the African-American Heart Failure Trial (A-HeFT) launched in 2001.2 A-HeFT enrolled 1,0...
متن کاملKidney disease progression and screening cost-effectiveness among African Americans.
Where is the wisdom we have lost in knowledge? Where is the knowledge we have lost in information? —T.S. Eliot The tragedy in the continuing disparities in the progression of CKD to ESRD and cardiovascular events for poor and disadvantaged (often minority) patients has not been somuch that disparities exist, but the lack of will to prioritize and implement actions to address the problem. This i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cleveland Clinic journal of medicine
دوره 81 5 شماره
صفحات -
تاریخ انتشار 2014